BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 118 filers reported holding BIOSCRIP INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $6,000 | -95.6% | 2,272 | -96.7% | 0.00% | -100.0% |
| Q1 2019 | $137,000 | +878.6% | 68,735 | +1660.6% | 0.01% | +700.0% |
| Q4 2018 | $14,000 | +55.6% | 3,904 | +36.8% | 0.00% | 0.0% |
| Q3 2018 | $9,000 | -18.2% | 2,854 | -54.8% | 0.00% | 0.0% |
| Q1 2017 | $11,000 | -84.7% | 6,318 | -39.2% | 0.00% | -90.0% |
| Q3 2014 | $72,000 | +1700.0% | 10,400 | +1980.0% | 0.01% | +900.0% |
| Q3 2013 | $4,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
| Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
| Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
| WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
| ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
| Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
| Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |